Academic Journal
Q1Lancet Neurology
About Lancet Neurology
Lancet Neurology is a scholarly journal published by Elsevier Ltd. SCImago 2025 places it in Q1 with an SJR of 12.439 and an H-index of 398.
Its listed coverage is 2002-2026 and its research categories include Neurology (clinical) (Q1). The 2025 dataset reports 251 documents and 9226 citations across the latest three-year reporting window.
The Lancet Neurology is one of the most prestigious and widely respected medical journals dedicated to the field of neurology. Part of the renowned Lancet family of journals, The Lancet Neurology publishes cutting-edge research, authoritative reviews, and expert commentary on a broad spectrum of topics related to neurological science and clinical neurology. Since its inception in 2002, the journal has become an essential resource for neurologists, neuroscientists, and healthcare professionals worldwide.
Trusted Source for Neurological Research
The Lancet Neurology is known for its rigorous peer-review process and high editorial standards, ensuring the publication of only the most reliable and impactful studies. It covers a wide array of neurological disorders including Alzheimer’s disease, Parkinson’s disease, stroke, epilepsy, multiple sclerosis, traumatic brain injury, and neuroinflammation. Each issue of the journal offers original research articles, comprehensive review papers, case studies, and clinical trial data that shape the future of neurological care.
Global Impact and Recognition
Ranked among the top journals in clinical neurology and neuroscience, The Lancet Neurology boasts a high impact factor, reflecting its role in influencing medical practice and research directions. The journal serves as a platform for international collaboration, bringing together research from diverse regions and healthcare systems. It is widely cited in academic publications and clinical guidelines, making it a go-to reference for evidence-based decision-making in neurological practice.
Topics and Features
Some of the most read and cited topics in The Lancet Neurology include:
-
Advances in neuroimaging and diagnostics
-
Breakthroughs in neurodegenerative disease research
-
Emerging therapies for stroke and brain injury
-
Pediatric neurology and developmental disorders
-
Innovations in neurosurgery and neurotechnology
The journal also features editorials and opinion pieces from leading experts, which provide critical insights into current challenges and ethical issues in the neurological sciences.
Commitment to Advancing Neurological Health
The Lancet Neurology is not only a publication but also a strong advocate for global neurological health. It frequently collaborates with institutions and initiatives aimed at reducing the global burden of neurological diseases. Its special issues and themed series highlight urgent topics such as neurological care in low-resource settings, the impact of environmental factors on brain health, and mental health in neurological conditions.
Digital Accessibility and Global Reach
The journal is available both in print and online, with a user-friendly website offering free access to editorials, abstracts, and select open-access content. Subscribers benefit from full access to all published articles, archives, and supplementary data. With a strong digital presence, The Lancet Neurology reaches a global audience of clinicians, researchers, policymakers, and students.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The Lancet Neurology is one of the world's leading journals in the field of clinical neurology. As a member of the prestigious Lancet family of medical journals, it is internationally respected for publishing groundbreaking research, insightful reviews, and expert opinion pieces that shape the future of neurological care. The scope of The Lancet Neurology is both broad and deeply specialized, covering a wide spectrum of neurological conditions and related disciplines.
Comprehensive Coverage of Neurological Disorders
The Lancet Neurology encompasses a diverse range of neurological disorders, including but not limited to:
-
Stroke and cerebrovascular diseases
-
Alzheimer's disease and other dementias
-
Parkinson's disease and movement disorders
-
Multiple sclerosis and autoimmune disorders
-
Epilepsy and seizure disorders
-
Neuromuscular diseases
-
Neuro-oncology
-
Neuroinfectious and neuroinflammatory diseases
This extensive coverage allows clinicians, researchers, and healthcare professionals to stay informed about the latest advancements in diagnosis, treatment, and patient care for various neurological conditions.
A Global Platform for High-Impact Research
One of the core strengths of The Lancet Neurology is its commitment to publishing high-impact, peer-reviewed original research. The journal actively promotes studies with global significance, encouraging research from diverse geographical regions and underrepresented populations. This international approach ensures that the research is relevant and applicable to neurology professionals across different healthcare settings.
Translational and Clinical Focus
The journal bridges the gap between laboratory science and clinical application. It features translational research that explores the mechanisms behind neurological diseases and how these discoveries can lead to effective therapies. Clinicians benefit from timely updates on new diagnostic techniques, clinical trials, treatment guidelines, and health policy developments that directly impact patient outcomes.
Reviews, Opinions, and Editorials
In addition to original research, The Lancet Neurology is known for its high-quality review articles, expert commentaries, and thought-provoking editorials. These pieces offer in-depth analysis and critical insights into emerging trends, ethical dilemmas, and policy challenges in the field of neurology.
Contribution to Evidence-Based Practice
By maintaining rigorous editorial standards, The Lancet Neurology plays a vital role in promoting evidence-based neurology. Its articles are frequently cited in clinical guidelines and healthcare policy documents, reflecting the journal’s influence on shaping clinical practice and improving patient care globally.
Recent Research Articles
Latest publications matched automatically by ISSN.
Guanabenz in vanishing white matter: towards mechanism-based disease modification
Geneviève Bernard
2026-09 · DOI: 10.1016/s1474-4422(26)00280-2Intensive blood pressure lowering after spontaneous intracerebral haemorrhage for secondary stroke prevention (RECAP-ICH): a systematic review and individual participant data meta-analysis
Xia Wang, Yijie Gao, M J Velasco, Katie Harris et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00244-9Gisela Terwindt: developing personalised prediction for migraine
Udani Samarasekera
2026-09 · DOI: 10.1016/s1474-4422(26)00292-9Safety and efficacy of guanabenz in early-childhood onset vanishing white matter: primary analysis of a single-arm, phase 1/2 trial
Marjo S van der Knaap, Renate J Verbeek, Romy J van Voorst, Elia Gonzato et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00241-3A unified evolutionary explanation of Parkinson's disease
Matthew J Farrer
2026-09 · DOI: 10.1016/s1474-4422(26)00296-6Finding more intracranial aneurysms that will never rupture
Kaiwen Wang, Qian Zhang, Zheng Wen, Chengcheng Zhu et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00315-7Epilepsy care must look beyond seizure control
The Lancet Neurology
2026-09 · DOI: 10.1016/s1474-4422(26)00291-7Music: a key component of brain health
Robert Stirrups
2026-09 · DOI: 10.1016/s1474-4422(26)00295-4Considerations on neurorehabilitation
Daphné Rimsky Robert, Karin Diserens, Jacques Luauté, Hugo Ardaillon et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00283-8Considerations on neurorehabilitation
Giovanni Morone, Marco Iosa, Rocco Salvatore Calabrò, Irene Ciancarelli et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00298-xBrain health: access for all
Tissa Wijeratne, David W Dodick, Steven L Lewis
2026-09 · DOI: 10.1016/s1474-4422(26)00282-6Maternal anti-seizure medications and fetal growth
Alexa King, Elizabeth Gerard
2026-09 · DOI: 10.1016/s1474-4422(26)00286-3Cholinesterase inhibitors and cardiac risk in dementia with Lewy bodies: keep the patient at heart
Jennifer G Goldman
2026-09 · DOI: 10.1016/s1474-4422(26)00289-9Cholinesterase inhibitors in people with dementia with Lewy bodies and cardiac conduction abnormalities
Sabrina Kalam, Judith Stellman, Robert Bell, Carla Abdelnour et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00231-0Social science research on dementia with Lewy bodies
Grant Gibson, Tiago Moreira, Martyn Pickersgill
2026-09 · DOI: 10.1016/s1474-4422(26)00281-4A little less conversation, a little more action
Jason D Warren
2026-09 · DOI: 10.1016/s1474-4422(26)00287-5Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study
Piero Perucca, Charles B Malpas, Alexander Berry-Noronha, Susan P Walker et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00216-4Marie E Luc and Charcot
Thany Sanches, Elise Alves dos Santos, Francesco Brigo, Olivier Walusinski et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00293-0Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis
Judith Dremel, Viktoria Rücker, Camilo Badel, Andreas Ziebart et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00276-0Advances in chronic subdural haematoma management: beyond the burr hole
Ellie Edlmann, Benjamin M Davies, Daniel J Stubbs, B Indira Devi et al.
2026-09 · DOI: 10.1016/s1474-4422(26)00288-7Reviews
Community Reviews
Version History
April 13, 2025 at 1:12 pm
April 13, 2025